Cancer antigen 15-3, platelet distribution width, and fibrinogen in combination to distinguish breast cancer from benign breast disease in non-conclusive mammography patients.

  title={Cancer antigen 15-3, platelet distribution width, and fibrinogen in combination to distinguish breast cancer from benign breast disease in non-conclusive mammography patients.},
  author={Shuang Fu and Zhi-yuan Yun and Ming-ming Cui and Hongxue Meng and Cheng Qian and Tiemin Liu and Zhi-Ping Liu and Rui-tao Wang and Kai-Jiang Yu},
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death among females. However, mammographic diagnosis is sometimes non-conclusive with a Breast imaging Reporting and Data System (Bi-RaDS) result of 0. Cancer antigen 15-3 (CA15-3) is the most widely used serum tumor marker for breast cancer screening. Platelet distribution width (PDW) is an early indicator of platelet activation. Fibrinogen contributed to angiogenesis and distant metastasis. The aim of this… 

Figures and Tables from this paper

Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer
Pre-chemotherapy D-dimer, fibrinogen, and pro-thrombin fragment 1+2 levels were significantly associated with tumor size and lymph node metastasis, and this finding stimulates future investigations addressing the role of plasma prothrom bin fragment 1-2 in the management of breast cancer patients to provide the rationale for new therapeutic strategies.
Diagnostic Value of Vascular Endothelial Growth Factor C (VEGF-C) and CA 15-3 in Breast Cancer
VEGF-C in combination with CA 15-3 performed better as diagnostic parameter and has better accuracy as a tumour marker for breast cancer in comparison with each marker alone.
Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer
The correlation between CTCs, hypercoagulability and reduced survival in MBC suggests the coagulation system supports tumour cell metastasis and is, therefore, a potential therapeutic target.


Using peripheral blood mRNA signature to distinguish between breast cancer and benign breast disease in non-conclusive mammography patients
Due to the small volume and high density of breast tissue in Asian women, particularly younger women, mammographic diagnosis is sometimes non-conclusive, with a Breast Imaging Reporting and Data
Mean platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancer
Changes in MPV values may be used as an easily available biomarker for monitoring the healthy patients for GC risk and may prompt physicians to make an early diagnosis of GC.
Pre-treatment mean platelet volume associates with worse clinicopathologic features and prognosis of patients with invasive breast cancer
High pre-treatment MPV level in IBC patients was a potential predictive factor and significant independent prognostic factor and correlations between pre- treatment MPV and clinical hematology parameters, pathology parameters and prognosis of patients with invasive breast cancer were investigated.
Elevated mean platelet volume is associated with presence of colon cancer.
The findings show that patients with colon cancer have higher MPV levels compared with controls, and these are reduced after surgery, and MPV was found to be independently associated with the presence of colon cancer.
Platelet-derived microparticles and coagulation activation in breast cancer patients.
It is speculated that platelet-derived microparticles (PMP) act in the microenvironment of tumor tissue and may thus not be an exclusive parameter reflecting in-vivo procoagulant activity.
Mean platelet volume could be a useful biomarker for monitoring epithelial ovarian cancer
The data suggests that MPV could be a promising and easily available biomarker for monitoring EOC patients and investigate the difference in MPV values between E OC patients and healthy controls.
Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis.
Prognostic significance of preoperative mean platelet volume in resected non-small-cell lung cancer.
It is demonstrated that a low MPV predicted an unfavorable prognosis in patients with NSCLC following curative resection, and was an independent unfavorable prognostic factor for DFS and OS.
Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer.
The prognostic significance of stromal PDGF beta-receptor expression was particularly prominent in tumors from premenopausal women and should be considered in ongoing clinical development of PDGF receptor inhibitors.